Viewing Study NCT06569420


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-01-04 @ 8:54 AM
Study NCT ID: NCT06569420
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-26
First Post: 2024-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module